The Infected Lungs and Brain Interface in COVID-19: The Impact on Cognitive Function
- 2 November 2022
- journal article
- review article
- Published by S. Karger AG in Neuroimmunomodulation
- Vol. 29 (4) , 269-281
Abstract
Many coronavirus disease 2019 (COVID-19)-recovered patients report signs and symptoms and are experiencing neurological, psychiatric, and cognitive problems. However, the exact prevalence and outcome of cognitive sequelae is unclear. Even though the severe acute respiratory syndrome coronavirus 2 has target brain cells through binding to angiotensin-converting enzyme 2 (ACE2) receptor in acute infection, several studies indicate the absence of the virus in the brain of many COVID-19 patients who developed neurological disorders. Thus, the COVID-19 mechanisms for stimulating cognitive dysfunction may include neuroinflammation, which is mediated by a sustained systemic inflammation, a disrupted brain barrier, and severe glial reactiveness, especially within the limbic system. This review explores the interplay of infected lungs and brain in COVID-19 and its impact on the cognitive function.Keywords
This publication has 121 references indexed in Scilit:
- Microglia across the lifespan: from origin to function in brain development, plasticity and cognitionThe Journal of Physiology, 2016
- The dynamic blood–brain barrierThe FEBS Journal, 2015
- T cell-mediated immune response to respiratory coronavirusesImmunologic Research, 2014
- Long-Term Cognitive Impairment after Critical IllnessNew England Journal of Medicine, 2014
- Matrix Metalloproteinase-2 and Metalloproteinase-9 Activities are Associated with Blood–Brain Barrier Dysfunction in an Animal Model of Severe SepsisMolecular Neurobiology, 2013
- Understanding brain dysfunction in sepsisAnnals of Intensive Care, 2013
- Pattern Recognition Receptors and the Innate Immune Response to Viral InfectionViruses, 2011
- Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsisIntensive Care Medicine, 2011
- The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunctionSeminars in Immunopathology, 2009
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004